Cancer a diagnostic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Breast Neoplastic Stem Cells Prostate Tumor Cells, Cultured MCF-7 Cells Lymph Nodes HCT116 Cells HT29 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases49

Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Disease Progression Carcinoma Carcinoma, Squamous Cell Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Endometrial Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Adenocarcinoma Liver Neoplasms Mouth Neoplasms Head and Neck Neoplasms Thyroid Neoplasms Bone Neoplasms Carcinoma, Small Cell Neoplasms, Radiation-Induced Skin Neoplasms Neoplasms, Hormone-Dependent Precancerous Conditions Neoplasms, Glandular and Epithelial Gastrointestinal Neoplasms Neoplasms, Second Primary Genital Neoplasms, Female Neovascularization, Pathologic Neoplasms, Multiple Primary Melanoma Kidney Neoplasms Mammary Neoplasms, Experimental Pharyngeal Neoplasms Adenoma Disease Models, Animal Carcinoma in Situ Carcinoma, Lobular Brain Neoplasms

Chemicals and Drugs47

Cancer Vaccines Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents Receptors, Estrogen RNA, Messenger Reagent Kits, Diagnostic Receptor, erbB-2 DNA, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Antigens, Neoplasm Tumor Suppressor Protein p53 Fluorouracil Tamoxifen Receptors, Progesterone Antibodies, Monoclonal Cisplatin Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal MicroRNAs Biological Markers Anticarcinogenic Agents Paclitaxel Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Radiopharmaceuticals Deoxycytidine RNA, Neoplasm Antimetabolites, Antineoplastic DNA-Binding Proteins Receptors, Androgen Taxoids DNA Primers BRCA2 Protein Transcription Factors Proto-Oncogene Proteins Carcinoembryonic Antigen Nuclear Proteins Androgens Antibodies, Monoclonal, Humanized BRCA1 Protein Carcinogens Estrogens CA-125 Antigen Proto-Oncogene Proteins c-akt Protein Kinase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Early Detection of Cancer Sensitivity and Specificity Diagnostic Errors Diagnostic Tests, Routine Retrospective Studies Diagnostic Imaging Prospective Studies Reproducibility of Results Prognosis Diagnostic Techniques and Procedures Predictive Value of Tests Follow-Up Studies Survival Analysis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Risk Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Risk Assessment Polymerase Chain Reaction Registries ROC Curve Xenograft Model Antitumor Assays Reagent Kits, Diagnostic Biopsy Risk Factors Odds Ratio Tomography, X-Ray Computed Blotting, Western Combined Modality Therapy Questionnaires Disease-Free Survival Neoplasm Transplantation Molecular Diagnostic Techniques Mammography Oligonucleotide Array Sequence Analysis Multivariate Analysis Chemotherapy, Adjuvant Transplantation, Heterologous Logistic Models Kaplan-Meier Estimate Clinical Trials as Topic Treatment Outcome Biopsy, Needle Tumor Burden Immunoenzyme Techniques Incidence SEER Program Molecular Targeted Therapy Enzyme-Linked Immunosorbent Assay Drug Screening Assays, Antitumor Confidence Intervals Genetic Testing Neoplasm Grading Tissue Array Analysis Models, Biological Immunohistochemistry Transfection Radiotherapy False Positive Reactions Prevalence Flow Cytometry Positron-Emission Tomography Magnetic Resonance Imaging Colonoscopy DNA Mutational Analysis Cohort Studies False Negative Reactions Early Diagnosis Real-Time Polymerase Chain Reaction Gene Knockdown Techniques Drug Administration Schedule Palliative Care Mammary Neoplasms, Experimental Diagnosis Clinical Laboratory Techniques Mastectomy Chi-Square Distribution Feasibility Studies Diagnosis, Computer-Assisted In Situ Hybridization, Fluorescence Disease Models, Animal Immunotherapy Pilot Projects Drug Delivery Systems Cross-Sectional Studies Radiotherapy, Adjuvant Regression Analysis Delayed Diagnosis Prostatectomy

Psychiatry and Psychology1

Phenomena and Processes43

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Risk Drug Resistance, Neoplasm Mutation Odds Ratio DNA Methylation Genotype Cell Survival Genes, BRCA1 Down-Regulation Cell Movement Polymorphism, Genetic Cell Division Dose-Response Relationship, Drug Cell Proliferation Cell Cycle Base Sequence Promoter Regions, Genetic Apoptosis Cell Growth Processes Algorithms Phenotype Time Factors Up-Regulation Transfection Genes, Neoplasm RNA Interference Genes, Tumor Suppressor Gene Silencing Germ-Line Mutation Gene Expression Postmenopause Genes, p53 Diet Genes, BRCA2 Alleles Signal Transduction Chi-Square Distribution Phosphorylation Epigenesis, Genetic Epithelial-Mesenchymal Transition

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science11

Survival Rate Registries Questionnaires Incidence SEER Program Diagnostic and Statistical Manual of Mental Disorders Molecular Sequence Data Base Sequence Algorithms Prevalence Diagnosis, Computer-Assisted

Named Groups2

Survivors European Continental Ancestry Group

Health Care40

Sensitivity and Specificity Diagnostic Errors Retrospective Studies Prospective Studies Reproducibility of Results Predictive Value of Tests Follow-Up Studies Survival Analysis Survival Rate Risk Risk Assessment Registries National Cancer Institute (U.S.)ROC Curve Age Factors Risk Factors Odds Ratio Questionnaires Disease-Free Survival Multivariate Analysis Logistic Models Kaplan-Meier Estimate Clinical Trials as Topic Treatment Outcome Diagnostic Services Incidence SEER Program Confidence Intervals Genetic Testing American Cancer Society Prevalence Cohort Studies Age Distribution Sex Factors Palliative Care Chi-Square Distribution Feasibility Studies Pilot Projects Cross-Sectional Studies Regression Analysis

Geographicals5

United States Japan China Europe Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Early Detection of Cancer Sensitivity and Specificity Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Diagnostic Errors Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Diagnostic Tests, Routine Retrospective Studies Diagnostic Imaging Gene Expression Regulation, Neoplastic Prospective Studies Reproducibility of Results Prognosis Diagnostic Techniques and Procedures Mice, Nude Predictive Value of Tests Cancer Vaccines Tumor Markers, Biological Neoplasm Proteins Follow-Up Studies Uterine Cervical Neoplasms Survival Analysis Genetic Predisposition to Disease Survival Rate Disease Progression Carcinoma Reverse Transcriptase Polymerase Chain Reaction Carcinoma, Squamous Cell Gene Expression Profiling Urinary Bladder Neoplasms Antineoplastic Agents United States Risk Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Neoplasm Staging Risk Assessment Polymerase Chain Reaction Drug Resistance, Neoplasm Mutation Registries National Cancer Institute (U.S.)ROC Curve Age Factors Receptors, Estrogen RNA, Messenger Xenograft Model Antitumor Assays Reagent Kits, Diagnostic Neoplasm Recurrence, Local Biopsy Risk Factors Receptor, erbB-2 Survivors Rectal Neoplasms Odds Ratio DNA, Neoplasm Tomography, X-Ray Computed Blotting, Western Prostate-Specific Antigen Combined Modality Therapy Endometrial Neoplasms Questionnaires Disease-Free Survival Neoplasm Transplantation Molecular Diagnostic Techniques Cell Transformation, Neoplastic DNA Methylation Mammography Genotype Oligonucleotide Array Sequence Analysis Smoking RNA, Small Interfering Esophageal Neoplasms Antigens, Neoplasm Multivariate Analysis Medical Oncology Chemotherapy, Adjuvant Adenocarcinoma Tumor Suppressor Protein p53 Liver Neoplasms Breast Cell Survival Transplantation, Heterologous Fluorouracil Tamoxifen Neoplastic Stem Cells Logistic Models Kaplan-Meier Estimate Mouth Neoplasms Receptors, Progesterone Clinical Trials as Topic

No FAQ available that match "cancer a diagnostic"